Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8+ cytotoxic T lymphocytes

Cancer Immunology, Immunotherapy

Volumn 50, Issue 9, 2001, Pages 445-455

  Bergmann Leitner, Elke S ^a   Abrams, Scott I ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Caspases; CTL; Human; Tumor immunity

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE INHIBITOR; CD8 ANTIGEN; CELL MARKER; CISPLATIN; FAS ANTIBODY; FLUOROURACIL; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; IRINOTECAN; LYMPHOCYTE SURFACE MARKER;

ANTIGEN SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CONTROL; CELL DEATH; CELL LINE; CELL SURFACE; CHEMOTHERAPY; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG HYDROLYSIS; EFFECTOR CELL; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOTHERAPY; METASTASIS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REGULATORY MECHANISM; TUMOR CELL;

ANTIGENS, CD95; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; APOPTOSIS; CAMPTOTHECIN; CASPASE 3; CASPASES; CD8-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; CHROMIUM; CISPLATIN; COLONIC NEOPLASMS; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; FLUOROURACIL; HUMANS; IN SITU NICK-END LABELING; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; RECOMBINANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0035171866     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620100229     Document Type: Article

References (33)

1. Mechanism of synergy of levamisole and fluorouracil: Induction of human leukocyte antigen class I in a colorectal cancer cell line
2. Effect of the combined treatment with 5-fluorouracil, gamma-interferon or folinic acid on carcinoembryonic antigen expression in colon cancer cells
3. + CTL
4. + cytotoxic T lymphocyte attack
5. + T lymphocyte neo-epitope created by a ras codon 12 mutation which is restricted by the HLA-A2 allele
6. Therapy with cultured T cells: Principles revisited
7. Specificity of adoptive chemoimmunotherapy of established syngeneic tumors
8. Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells
9. Increased sensitivity of adriamycin-selected tumor lines to CTL-mediated lysis results in enhanced drug sensitivity
10. Cytotoxic drugs and the CD95 pathway
11. DNA strand breaks occurring in apoptosis: Their early in situ detection by the terminal deoxynucleotidyl transferase and nick translation assays and prevention by serine protease inhibitors
12. Induction of DNA strand breaks associated with apoptosis during treatment of leukemias
13. Adoptive T cell therapy of tumors: Mechanisms operative in the recognition and elimination of tumor cells
14. Cancer vaccines
15. Topoisomerase enzymes as drug targets
16. Advances in cancer vaccine development
17. Defective apoptotic signal transduction pathway downstream of caspase-3 in human B-lymphoma cells: A novel mechanism of nuclear apoptosis resistance
18. Classification of human colorectal adenocarcinoma cell lines
19. The effects of gamma-interferon combined with 5-fluorouracil or 5-fluoro-2'-deoxyuridine on proliferation and antigen expression in a panel of human colorectal cancer cell lines
20. Cisplatin induces las expression in esophageal cancer cell lines and enhanced cytotoxicity in combination with LAK cells
21. Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity
22. STAT-l-independent upregulation of FADD and procaspase-3 and -8 in cancer cells treated with cytotoxic drugs
23. Chemoimmunosensitization of the T24 human bladder cancer line to Fas-mediated cytotoxicity and apoptosis by cisplatin and 5-fluorouracil
24. Adjuvant therapy of colon cancer
25. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs
26. Cancer vaccines
27. Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1
28. Different interleukin-1 beta converting enzyme (ICE) family protease requirements for the apoptotic death of T lymphocytes triggered by diverse stimuli
29. Apoptosis signaling by death receptors
30. Activation of the Fas pathway independently of Fas ligand during apoptosis induced by camptothecin in p53 mutant human colon carcinoma cells
31. Apoptosis signaling
32. 5-Fluorouracil increases susceptibility of renal cell cancer cell lines to lymphokine-activated killer cells: Evidence for alteration not at the level of recognition but at a postbinding stage of the lytic cycle
33. Cyclophosphamide enhances anti-tumor effect of wildtype p53-specific CTL